Marvel Biosciences Announces Private Placement Update

Calgary, Alberta--(Newsfile Corp. - June 21, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), wishes to announce that, further to Marvel's May 16, 2024 press release announcing the Company's non-brokered private placement unit offering (the "Offering"), the TSX Venture Exchange ("TSXV" or the "Exchange") has conditionally accepted the Company's proposed Offering and has granted the Company a two-week extension ...